By distribution channel, hospital pharmacies led with 64.72% revenue share in 2025, whereas online and tele-pharmacies record the highest projected CAGR at 6.88% to 2031
Generally, candidates for GLP-1 medications like Saxenda have a Body Mass Index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity, such as type 2 diabetes, high blood pressure, or high cholesterol
The thicket maze: A strategic guide to navigating and dismantling drug patent fortresses
Clinical takeaway: In hypertensive patients, combining glycemic status with cardiac biomarker profiling may substantially improve heart failure risk stratification and enable earlier, precision-based preventioneven before diabetes or overt symptoms develop
"It's really amazing to see it when it works," she said
OShea and his team do note that this research was a proof-of-concept study, so more work will be needed to confirm the findings here